With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Mortality rates decreased sixfold and hospital admissions decreased threefold in children with HIV who received antiretroviral therapy, according to the findings of a study conducted in Zambia. The ...
Investigators newly identified pre-existing cardiac disorders in cotrimoxazole users as an AKI risk factor. Due to increasing antimicrobial resistance, clinicians have returned to using older agents ...
Several trimethoprim-sulfamethoxazole (TMP-SMX, cotrimoxazole) dosing strategies are acceptable for Pneumocystis pneumonia (PCP) chemoprophylaxis, and this can cause confusion about the correct dose ...
TORONTO, ON — The risk of sudden death went up by more than a third in older patients taking ACE inhibitors or angiotensin-receptor blockers (ARBs) who were also put on the antibacterial agent ...
Photo taken in Bangkok, Thailand Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with ...
To compare the effectiviness of spiramycin/cotrimoxazole (Sp/C) versus pyrimethamine/sulfonamide (Pyr/Sul) and spiramycin alone (Spy) on mother-to-child transmission ...
Cotrimoxazole (CTX) discontinuation is inferior to CTX continuation among ART-treated, immune-reconstituted HIV-infected adults living in a malaria-endemic region, according to results of a recent ...
Developments in health care and research warrant updates to the World Health Organization (WHO) guidelines on cotrimoxazole prophylaxis for infants who are exposed to HIV but uninfected. The World ...
You have full access to this article via your institution. Many SCT centers differ in their use of cotrimoxazole prophylaxis with regard to either interrupting or not, or in using non-myelotoxic drugs ...
The Blizard Institute's Dr Claire Bourke and Dr Andrew Prendergast and colleagues had research published this week in the journal Science Translational Medicine, which shows for the first time that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results